SCHEMBL966165

SCHEMBL966165

CCCCCOC(=O)CC(CC(=O)OCCCCC)(OC(C)=O)C(=O)OCCCCC

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.49
ALDH1A1 P00352 1/20 0.44
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
FAAH O00519 1/20 0.41
TSHR P16473 2/20 0.41
DGKA P23743 1/20 0.41
HTR2C P28335 1/20 0.41
EPHX1 P07099 1/20 0.39
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTT P42858 1/20 0.37
CES2 O00748 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168358 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL17812705 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL169210 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL10392986 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL17812757 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL11074423 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL17812732 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL1957839 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL17812645 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH
SCHEMBL9068348 0.98 NAAA (0.51) NAAAALDH1A1RAD52NPSR1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115698168-A Decorative panel and decorative floor covering composed of said panel I4F许可有限责任公司 2023-02-03 CN claimed
CN-111298667-B Polymer-based blended film, and preparation method and application thereof 中国科学院大连化学物理研究所 2021-12-07 CN claimed
CN-113365809-A Decorative panel and decorative floor covering composed of said panel I4F许可有限责任公司 2021-09-07 CN claimed
CN-109280112-B Catalyst composition suitable for propylene homopolymerization or copolymerization 任丘市利和科技发展有限公司 2021-06-08 CN claimed
EP-4385529-A2 DEVICES FOR CONTROLLED DELIVERY Femasys, Inc. (US) 2024-06-19 EP disclosed
EP-3787533-B1 DEVICES FOR CONTROLLED DELIVERY FEMASYS INC (US) 2024-04-17 EP disclosed
US-20230390105-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC 2023-12-07 US disclosed
US-20230329900-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY FEMASYS INC. 2023-10-19 US disclosed
US-11744729-B2 Methods and devices for controlled delivery FEMASYS INC. (US) 2023-09-05 US disclosed
WO-2023120638-A1 MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM 東ソー株式会社 2023-06-29 WO disclosed
CN-115698168-A Decorative panel and decorative floor covering composed of said panel I4F许可有限责任公司 2023-02-03 CN disclosed
CN-111298667-B Polymer-based blended film, and preparation method and application thereof 中国科学院大连化学物理研究所 2021-12-07 CN disclosed
EP-2268727-A1 POLYOL ESTER PLASTICIZERS AND PROCESS OF MAKING THE SAME ExxonMobil Chemical Patents Inc. (US) 2011-01-05 EP disclosed
EP-2219553-A1 SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE Valor Medical, Inc. (US) 2010-08-25 EP disclosed
US-20090257976-A1 SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE VALOR MEDICAL, INC. (US) 2009-10-15 US disclosed
WO-2009118261-A1 POLYOL ESTER PLASTICIZERS AND PROCESS OF MAKING THE SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2009-10-01 WO disclosed
US-7595421-B2 Tripentyl citrates and their use OXENO OLEFINCHEMIE GMBH (DE) 2009-09-29 US disclosed
WO-2009064698-A1 SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE VALOR MEDICAL, INC. (US) 2009-05-22 WO disclosed
US-20070287781-A1 TRIPENTYL CITRATES AND THEIR USE OXENO OLEFINCHEMIE GMBH (DE) 2007-12-13 US disclosed
US-4010253-A Process of suppressing odors employing deodorants containing esters of citric acid HENKEL & CIE G.M.B.H. (DT) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090257976-A1 SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE MMAB, CBL, ECPAS NAAA 1050/4885ALDH1A1 1713/4885RAD52 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.